Skip to search formSkip to main contentSkip to account menu

0.05 ML aflibercept 40 MG/ML Injection [Eylea]

Known as: aflibercept 40 mg in 1 mL INTRAVITREAL INJECTION, SOLUTION [EYLEA], Eylea 2 MG per 0.05 ML Intravitreal Injection, EYLEA 2 MG in 0.05 ML Injection 
National Institutes of Health

Related topics

Related topics

9 relations

Broader (2)

0.05 ML aflibercept 40 MG/ML Injectionaflibercept Injection [Eylea]
EyleaInjectionPolysorbate 20Sodium Chloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Four-year outcomes of aflibercept treatment for neovascular age-related macular degeneration: Results from real-life setting
Background: To assess long-term structural and functional outcomes of intravitreal aflibercept (Eylea®) treatment for neovascular… 
2020
2020
OPTICAL COHERENCE TOMOGRAPHY PREDICTORS OF SHORT-TERM VISUAL ACUITY IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL CONBERCEPT.
PURPOSE To identify the spectral domain optical coherence tomography predictors of visual prognosis in retinal vein occlusion… 
2020
2020
Safety of Intravitreal Injection of Biosimilar of Aflibercept in Rabbit Eyes
Purpose To assess the safety of biosimilar intravitreal aflibercept (CinnaGen Co., Iran) compared to the reference product (Eylea… 
2019
2019
Outcomes in patients receiving fixed-dosed aflibercept for treatment-naïve neovascular age-related macular degeneration during one year of routine clinical practice.
2019
2019
Dermatite périoculaire au cours du traitement d’une DMLA : polysensibilisation à l’EYLEA® (aflibercept) et aux collyres tétracaïne et azythromycine
2018
2018
The involvement of NK1 and Y2 receptor in the development of laser‐induced CNVs in C57Bl/6N mice
2016
2016
23-Gauge Pars Plana Vitrectomy Alone by a Bimanual Technique for the Removal of Dense Posteriorly Dislocated Crystalline Lens
Background: We sought to verify the efficacy and safety of transconjunctival 23-gauge pars plana vitrectomy (PPV) alone by our… 
2016
2016
Thrombotic microangiopathy from intravitreal eylea (aflibercept) use for macular eye degeneration
2015
2015
Aflibercept (Eylea®) for Refractory Diabetic Macular Edema
Review
2015
Review
2015
RECALCITRANT CYSTOID MACULAR EDEMA AFTER PARS PLANA VITRECTOMY
Purpose: To evaluate the outcomes of different types of treatment of chronic cystoid macular edema (CME) after pars plana… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)